NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$17.16
-0.18 (-1.04%)
βΌ
5d:
-2.05%
30d:
+30.79%
90d:
-8.58%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 27, 2026
23d
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
β BUY SIGNAL: NRC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
β BUY SIGNAL: NRC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $17.16, which is considered slightly high relative to its 30-day fair value range of $13.91 to $17.59.
Technical Outlook: Technically, NRC is showing sideways momentum. Immediate support is located at $16.53, while resistance sits at $17.84.
Market Sentiment: NRC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NRC is showing sideways momentum. Immediate support is located at $16.53, while resistance sits at $17.84.
Market Sentiment: NRC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$13.91 -
$17.59
Company Quality Score
58/100
(HOLD)
Options IV Signal
18th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
81.8%
All Signals
- BULLISH: Options cheap (IV 18th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
Fair Price Analysis
30-Day Fair Range
$13.91 -
$17.59
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
Β±$0.93
(5.4%)
Support & Resistance Levels
Support Level
$16.53
Resistance Level
$17.84
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Revenue Growth (YoY)
-4.6%
Earnings Growth (YoY)
-74.4%
Profit Margin
8.4%
Share & Embed Analysis
Last updated: April 02, 2026 7:06 PM ET
Data refreshes hourly during market hours. Next update: 8:06 PM
Data refreshes hourly during market hours. Next update: 8:06 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 60 BUY |
|
GEHC
GE HealthCare Technologi⦠|
STRONG BUY
21 analysts |
$90 | 62 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 67 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 52 HOLD |